(Q43860872)

27 November 2017

title

Insulinlike growth factor-1 in lung transplants with obliterative bronchiolitis (English)

1 reference

27 November 2017

0 references

1 reference

Charpin JM

1

1 reference

27 November 2017

Stern M

series ordinal

2

1 reference

27 November 2017

Grenet D

series ordinal

3

1 reference

27 November 2017

Israël-Biet D

series ordinal

4

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

American Journal of Respiratory and Critical Care Medicine

27 November 2017

published in

1 reference

27 November 2017

volume

161

1 reference

27 November 2017

issue

6

1 reference

27 November 2017

page(s)

1991-1998

1 reference

Bronchiolitis obliterans: pathogenesis, prevention, and management

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9905049

Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9905049

Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9905049

Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation--early risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9905049

Prolonged ischemia is associated with more pronounced rejection in the lung allograft.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9905049

Mechanisms of pulmonary fibrosis. Spontaneous release of the alveolar macrophage-derived growth factor in the interstitial lung disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9905049

Stimulation of collagen formation by insulin and insulin-like growth factor I in cultures of human lung fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9905049

Alveolar macrophages release an insulin-like growth factor I-type molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9905049

Enhanced insulin-like growth factor molecules in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9905049

Mechanisms of fibrosis in coal workers' pneumoconiosis. Increased production of platelet-derived growth factor, insulin-like growth factor type I, and transforming growth factor beta and relationship to disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9905049

Expression of insulin-like growth factor binding proteins in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9905049

Expression of insulin-like growth factors and their binding proteins by bronchoalveolar cells from children with and without interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9905049

Complete nucleotide sequence of the high molecular weight human IGF-I mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9905049

Measurement of gene expression by multiplex competitive polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9905049

Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.6.9905049

10.1164/AJRCCM.161.6.9905049

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference